Outcomes and Risk of PF-ILD in Primary Sjogren's Syndrome Outcomes and Risk of PF-ILD in Primary Sjogren's Syndrome
This study provides new insights into the risk factors and survival outcomes for progressive pulmonary fibrosis among primary Sjogren ' s syndrome patients with interstitial lung disease.BMC Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 22, 2023 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news
Filgotinib, Lanraplenib and Tirabrutinib in Sjogren Syndrome Filgotinib, Lanraplenib and Tirabrutinib in Sjogren Syndrome
Could these drugs prove to be a safe and effective option for the treatment of Sjogren ' s syndrome?Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 3, 2023 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Novel BTK Inhibitor Looks Good for Sjogren's Syndrome
(MedPage Today) -- PHILADELPHIA -- Remibrutinib, an investigational Bruton's tyrosine kinase (BTK) inhibitor, appeared effective in reducing signs of Sjogren's syndrome in a randomized, placebo-controlled trial.
Scores on the EULAR Sjogren's... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 14, 2022 Category: Rheumatology Source Type: news
Sjogren's Responds to Cytokine Treatment, Early Data Show
(MedPage Today) -- Most patients with Sjogren's syndrome treated with low doses of interleukin-2 (IL-2) in a randomized, placebo-controlled trial showed significant improvement, researchers said.
After 24 weeks in the 60-person trial, 66.7% of... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 11, 2022 Category: Rheumatology Source Type: news
Outcome and Factors of Lymphoma in Sjogren's Syndrome Outcome and Factors of Lymphoma in Sjogren's Syndrome
Primary Sjogren ' s syndrome is associated with an increased risk of non-Hodgkin ' s lymphoma. What do we know about the clinical features and survival of these patients?Rheumatology (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 5, 2022 Category: Pathology Tags: Rheumatology Journal Article Source Type: news
Sjogren's Syndrome With Nervous System Injury and Cryptococcosis Sjogren's Syndrome With Nervous System Injury and Cryptococcosis
This case details a rare form of neural involvement in Sjogren ' s syndrome, combined with pulmonary and osseous cryptococcosis due to long-term use of high-dose corticosteroids and immunosuppressants.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 12, 2021 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news
What's New in Ocular and Oral Aspects of Sjogren's Syndrome What's New in Ocular and Oral Aspects of Sjogren's Syndrome
Get up-to-date on the most recent advancements in the diagnosis and treatment of ocular and oral manifestations of primary Sjogren ' s syndrome.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 7, 2021 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
How Is Sjogren's Syndrome Diagnosed and Treated?
Title: How Is Sjogren ' s Syndrome Diagnosed and Treated?Category: Diseases and ConditionsCreated: 2/17/2021 12:00:00 AMLast Editorial Review: 2/17/2021 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - February 17, 2021 Category: Rheumatology Source Type: news
What Triggers Sjogren's Syndrome?
Title: What Triggers Sjogren ' s Syndrome?Category: Diseases and ConditionsCreated: 1/8/2021 12:00:00 AMLast Editorial Review: 1/8/2021 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - January 8, 2021 Category: Rheumatology Source Type: news
How Sjogren Syndrome Intersects With COVID-19 How Sjogren Syndrome Intersects With COVID-19
Physicians Robert Fox and Alan N. Baer discuss the latest research on Sjogren ' s, presented at the ACR Convergence virtual meeting.Medscape Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 24, 2020 Category: Consumer Health News Tags: Rheumatology Commentary Source Type: news
Sjogren's Syndrome
Title: Sjogren ' s SyndromeCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 9/3/2020 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - September 3, 2020 Category: Rheumatology Source Type: news
Oral Disorders and HRQoL in Patients With Sjogren's Syndrome Oral Disorders and HRQoL in Patients With Sjogren's Syndrome
How prevalent is chemosensory dysfunction, such as impaired sense of taste or smell, or oral disorders such as burning mouth syndrome, in patients with primary Sjogren ' s syndrome?BMC Oral Health (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 31, 2020 Category: Consumer Health News Tags: Dental & Oral Health Journal Article Source Type: news
Combination Leflunomide-Hydroxychloroquine Promising for Sjogren's Syndrome Combination Leflunomide-Hydroxychloroquine Promising for Sjogren's Syndrome
A combination of two approved drugs, leflunomide and hydroxychloroquine, was safe and elicited a clinical response in a phase-2a trial for Sjogren ' s syndrome.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 7, 2020 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Seasonality and Fatigue, Pain, Dryness in Sjogren's Syndrome Seasonality and Fatigue, Pain, Dryness in Sjogren's Syndrome
In what ways might seasonal variations impact these symptoms in patients with primary Sjogren ' s syndrome?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 24, 2020 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Iscalimab Promising for Sjogren's Syndrome Iscalimab Promising for Sjogren's Syndrome
The anti-CD40 monoclonal antibody iscalimab showed preliminary efficacy against Sjogren ' s syndrome in a proof-of-concept study.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 19, 2020 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
